PubRank

Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan

Clinical Trial ID NCT04671186

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04671186

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005 33.66
2 Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006 18.83
3 Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012 10.74
4 Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2014 3.28
5 Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2014 2.90
6 Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013 1.84
7 Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 2012 1.64
8 Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013 1.44
9 Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr 2011 1.41
10 Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol 2010 1.17
11 Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr 2009 1.14
12 Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 2013 0.96
13 Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. World J Gastroenterol 2014 0.96
14 The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 2016 0.93
15 Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol 2015 0.78
16 NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017 0.78
17 Gut Microbiota: Association with NAFLD and Metabolic Disturbances. Biomed Res Int 2015 0.77
18 Nonalcoholic fatty liver disease. Pediatr Rev 2015 0.76
Next 100